These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 32882331)

  • 1. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome.
    Gómez J; Albaiceta GM; García-Clemente M; López-Larrea C; Amado-Rodríguez L; Lopez-Alonso I; Hermida T; Enriquez AI; Herrero P; Melón S; Alvarez-Argüelles ME; Boga JA; Rojo-Alba S; Cuesta-Llavona E; Alvarez V; Lorca R; Coto E
    Gene; 2020 Dec; 762():145102. PubMed ID: 32882331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients.
    Verma S; Abbas M; Verma S; Khan FH; Raza ST; Siddiqi Z; Ahmad I; Mahdi F
    Infect Genet Evol; 2021 Jul; 91():104801. PubMed ID: 33676010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.
    Karakaş Çelik S; Çakmak Genç G; Pişkin N; Açikgöz B; Altinsoy B; Kurucu İşsiz B; Dursun A
    J Med Virol; 2021 Oct; 93(10):5947-5952. PubMed ID: 34170561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.
    Gemmati D; Tisato V
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype.
    Yamamoto N; Ariumi Y; Nishida N; Yamamoto R; Bauer G; Gojobori T; Shimotohno K; Mizokami M
    Gene; 2020 Oct; 758():144944. PubMed ID: 32628976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).
    Guo X; Chen Z; Xia Y; Lin W; Li H
    J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNPs of ACE1 (rs4343) and ACE2 (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease.
    Alimoradi N; Sharqi M; Firouzabadi D; Sadeghi MM; Moezzi MI; Firouzabadi N
    Virol J; 2022 Mar; 19(1):48. PubMed ID: 35305693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single Nucleotide Variants (SNVs) of Angiotensin-Converting Enzymes (ACE1 and ACE2): A Plausible Explanation for the Global Variation in COVID-19 Prevalence.
    Atiku SM; Kasozi D; Campbell K
    J Renin Angiotensin Aldosterone Syst; 2023; 2023():9668008. PubMed ID: 37051471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
    Gemmati D; Bramanti B; Serino ML; Secchiero P; Zauli G; Tisato V
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients.
    Novelli A; Biancolella M; Borgiani P; Cocciadiferro D; Colona VL; D'Apice MR; Rogliani P; Zaffina S; Leonardis F; Campana A; Raponi M; Andreoni M; Grelli S; Novelli G
    Hum Genomics; 2020 Sep; 14(1):29. PubMed ID: 32917283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality.
    Mir MM; Mir R; Alghamdi MAA; Alsayed BA; Wani JI; Alharthi MH; Al-Shahrani AM
    J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation.
    Alshahawey M; Raslan M; Sabri N
    Curr Res Transl Med; 2020 Nov; 68(4):149-150. PubMed ID: 32917573
    [No Abstract]   [Full Text] [Related]  

  • 13.
    Yamamoto N; Nishida N; Yamamoto R; Gojobori T; Shimotohno K; Mizokami M; Ariumi Y
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of ACE2 polymorphisms (rs1978124, rs2285666, and rs2074192) and ACE1 rs1799752 in the mortality rate of COVID-19 in different SARS-CoV-2 variants.
    Sheikhian F; Sadeghi Mofrad S; Tarashi S; Ghazanfari Jajin M; Sakhaee F; Ahmadi I; Anvari E; Sheikhpour M; Fateh A
    Hum Genomics; 2023 Jun; 17(1):54. PubMed ID: 37328914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?
    Lippi G; Lavie CJ; Henry BM; Sanchis-Gomar F
    Clin Chem Lab Med; 2020 Aug; 58(9):1415-1422. PubMed ID: 32598305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.
    Tsiambas E; Papanikolaou V; Chrysovergis A; Mastronikolis N; Ragos V; Kavantzas N; Lazaris AC; Kyrodimos E
    Pathol Oncol Res; 2020 Oct; 26(4):2823-2825. PubMed ID: 32333199
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 infections are also affected by human ACE1 D/I polymorphism.
    Delanghe JR; Speeckaert MM; De Buyzere ML
    Clin Chem Lab Med; 2020 Jun; 58(7):1125-1126. PubMed ID: 32286246
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis.
    Saengsiwaritt W; Jittikoon J; Chaikledkaew U; Udomsinprasert W
    Rev Med Virol; 2022 Jul; 32(4):e2323. PubMed ID: 34997794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis.
    Hou Y; Zhao J; Martin W; Kallianpur A; Chung MK; Jehi L; Sharifi N; Erzurum S; Eng C; Cheng F
    BMC Med; 2020 Jul; 18(1):216. PubMed ID: 32664879
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Martínez-Gómez LE; Herrera-López B; Martinez-Armenta C; Ortega-Peña S; Camacho-Rea MDC; Suarez-Ahedo C; Vázquez-Cárdenas P; Vargas-Alarcón G; Rojas-Velasco G; Fragoso JM; Vidal-Vázquez P; Ramírez-Hinojosa JP; Rodríguez-Sánchez Y; Barrón-Díaz D; Moreno ML; Martínez-Ruiz FJ; Zayago-Angeles DM; Mata-Miranda MM; Vázquez-Zapién GJ; Martínez-Cuazitl A; Barajas-Galicia E; Bustamante-Silva L; Zazueta-Arroyo D; Rodríguez-Pérez JM; Hernández-González O; Coronado-Zarco R; Lucas-Tenorio V; Franco-Cendejas R; López-Jácome LE; Vázquez-Juárez RC; Magaña JJ; Cruz-Ramos M; Granados J; Hernández-Doño S; Delgado-Saldivar D; Ramos-Tavera L; Coronado-Zarco I; Guajardo-Salinas G; Muñoz-Valle JF; Pineda C; Martínez-Nava GA; López-Reyes A
    Front Immunol; 2022; 13():812940. PubMed ID: 35250987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.